secwatch.observer — SEC 8-K summary
======================================

Issuer:     Petros Pharmaceuticals, Inc. (PTPI)
CIK:        0001815903
Form:       8-K
Filed at:   2025-11-07T23:59:59+00:00
Accession:  0001104659-25-108552
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq notifies Petros Pharmaceuticals of common stock delisting effective Nov 7, 2025
--------------------------------------------------------------------------------

- Nasdaq notified Petros on Nov 3, 2025, of intention to delist common stock on Nov 7, 2025.
- Stock suspended from Nasdaq Capital Market on May 22, 2025; trading on OTCID since July 1, 2025.
- Nasdaq to file Form 25 to deregister stock under Section 12(b); delisting effective 10 days later.
- Common stock continues trading on OTCID symbol PTPI without disruption; SEC reporting obligations remain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815903/000110465925108552/0001104659-25-108552-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815903/000110465925108552/tm2530149d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-108552

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer